Immunological impact of magnetic nanoparticles (Ferucarbotran) on murine peritoneal macrophages

Journal of Nanoparticle Research

Volumn 12, Issue 1, 2010, Pages 151-160

  Yeh, Chen Hao ^a   Hsiao, Jong Kai ^b   Wang, Jaw Lin ^a   Sheu, Fuu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cell activation; Chemotaxis; Cytotoxicity; Inflammation; Magnetic resonance imaging; Nanomedicine; Superparamagnetic iron oxide

Indexed keywords

BIOLOGICAL EFFECTS; CELL ACTIVATION; CHEMOTACTIC RESPONSE; CHEMOTAXIS; CYTOKINE SECRETIONS; CYTOKINES; HIGH DOSE; IMMUNOLOGICAL IMPACT; IN-VIVO; MAGNETIC NANOPARTICLES; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; MRNA EXPRESSION; MURINE PERITONEAL MACROPHAGES; NANOMEDICINES; RECIRCULATIONS; SUPERPARAMAGNETIC IRON OXIDES;

BIOCHEMISTRY; CYTOLOGY; MACROPHAGES; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MAGNETISM; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NITRIC OXIDE; PATHOLOGY; SUPERPARAMAGNETISM;

IRON OXIDES;

FERUCARBOTRAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NANOPARTICLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CHEMOTAXIS; CONCENTRATION RESPONSE; CYTOKINE RELEASE; CYTOPLASM; CYTOTOXICITY; FEMALE; GRANULAR CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MAGNETISM; MOUSE; NANOMEDICINE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 75049084154     PISSN: 13880764     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11051-009-9589-y     Document Type: Article

References (35)

1. AS Arbab LA Bashaw BR Miller, et al. 2003 Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging Radiology 229 838 846 10.1148/radiol.2293021215 10.1148/radiol.2293021215 14657318 (Pubitemid 37467591)
2. AS Arbab GT Yocum H Kalish, et al. 2004 Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI Blood 104 1217 1223 10.1182/blood-2004-02-0655 10.1182/blood-2004-02-0655 1:CAS:528: DC%2BD2cXmslKgtr8%3D 15100158 (Pubitemid 39038047)
3. AS Arbab GT Yocum AM Rad, et al. 2005 Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells NMR Biomed 18 553 559 10.1002/nbm.991 10.1002/nbm.991 1:CAS:528:DC%2BD28XosVSqtQ%3D%3D 16229060 (Pubitemid 43013896)
4. J Barlic JM Sechler PM Murphy 2003 IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1 Blood 102 3494 3503 10.1182/blood-2003-03-0946 10.1182/blood-2003-03-0946 1:CAS:528: DC%2BD3sXptVymsbk%3D 12881312 (Pubitemid 37409364)
5. JF Bazan KB Bacon G Hardiman, et al. 1997 A new class of membrane-bound chemokine with a CX3C motif Nature 385 640 644 10.1038/385640a0 10.1038/385640a0 1:CAS:528:DyaK2sXht1yks7w%3D 9024663 1997Natur.385..640B (Pubitemid 27087578)
6. JJ Chen YC Lin PL Yao, et al. 2005 Tumor-associated macrophages: the double-edged sword in cancer progression J Clin Oncol 23 953 964 10.1200/JCO.2005.12.172 10.1200/JCO.2005.12.172 1:CAS:528:DC%2BD2MXit1Ggu7Y%3D 15598976 (Pubitemid 46202315)
7. C Corot KG Petry R Trivedi, et al. 2004 Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging Invest Radiol 39 619 625 10.1097/01.rli.0000135980.08491.33 10.1097/01.rli.0000135980.08491.33 1:CAS:528:DC%2BD2cXns1ertro%3D 15377941 (Pubitemid 39287601)
8. C Corot P Robert JM Idee M Port 2006 Recent advances in iron oxide nanocrystal technology for medical imaging Adv Drug Deliv Rev 58 1471 1504 10.1016/j.addr.2006.09.013 10.1016/j.addr.2006.09.013 1:CAS:528: DC%2BD28Xht1KmtLbP 17116343 (Pubitemid 44820503)
9. HE Daldrup-Link M Rudelius RA Oostendorp, et al. 2003 Targeting of hematopoietic progenitor cells with MR contrast agents Radiology 228 760 767 10.1148/radiol.2283020322 10.1148/radiol.2283020322 12881578 (Pubitemid 37025487)
10. SJ Dodd M Williams JP Suhan DS Williams AP Koretsky C Ho 1999 Detection of single mammalian cells by high-resolution magnetic resonance imaging Biophys J 76 103 109 10.1016/S0006-3495(99)77182-1 1:CAS:528:DyaK1MXjsFKrsQ%3D%3D 9876127
11. V Dousset C Delalande L Ballarino, et al. 1999 In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance Magn Reson Med 41 329 333 10.1002/(SICI)1522-2594(199902)41:2<329::AID- MRM17>3.0.CO;2-Z 10.1002/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3. 0.CO;2-Z 1:STN:280:DyaK1M7nvVeltA%3D%3D 10080281 (Pubitemid 29104519)
12. S Floris EL Blezer G Schreibelt, et al. 2004 Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study Brain 127 616 627 10.1093/brain/awh068 10.1093/brain/awh068 1:STN:280:DC%2BD2c7gtVSluw%3D%3D 14691063 (Pubitemid 38295477)
13. G Fotakis JA Timbrell 2006 In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride Toxicol Lett 160 171 177 10.1016/j.toxlet.2005.07. 001 10.1016/j.toxlet.2005.07.001 1:CAS:528:DC%2BD2MXhtFOhtbnE 16111842 (Pubitemid 41578961)
14. JC Gevrey BM Isaac D Cox 2005 Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine) J Immunol 175 3737 3745 1:CAS:528: DC%2BD2MXpslClsrY%3D 16148119
15. LC Green DA Wagner J Glogowski PL Skipper JS Wishnok SR Tannenbaum 1982 Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem 126 131 138 10.1016/0003-2697(82)90118-X 10.1016/0003-2697(82)90118-X 1:CAS:528:DyaL38XlvFGgtLY%3D 7181105 (Pubitemid 13203451)
16. B Hamm T Staks M Taupitz 1994 SHU 555A A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging Invest Radiol 29 Suppl 2 S87 S89 10.1097/00004424-199406001-00029 7928280
17. B Hamm T Staks M Taupitz, et al. 1994 Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide J Magn Reson Imaging 4 659 668 10.1002/jmri.1880040508 10.1002/jmri.1880040508 1:STN:280:DyaK2M%2Fnt1ektg%3D%3D 7981510
18. KA Hinds JM Hill EM Shapiro, et al. 2003 Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells Blood 102 867 872 10.1182/blood-2002-12-3669 10.1182/blood-2002-12-3669 1:CAS:528: DC%2BD3sXlvFCmsb8%3D 12676779 (Pubitemid 36917777)
19. JK Hsiao HH Chu YH Wang, et al. 2008 Macrophage physiological function after superparamagnetic iron oxide labeling NMR Biomed 21 820 829 10.1002/nbm.1260 10.1002/nbm.1260 1:CAS:528:DC%2BD1cXht1KqtrnI 18470957
20. P Jendelova V Herynek J De Croos, et al. 2003 Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles Magn Reson Med 50 767 776 10.1002/mrm.10585 10.1002/mrm.10585 1:CAS:528:DC%2BD3sXosFClu7o%3D 14523963 (Pubitemid 37187842)
21. ES Kimball E Kovacs MC Clark CR Schneider 1995 Activation of cytokine production and adhesion molecule expression on THP-1 myelomonocytic cells by macrophage colony-stimulating factor in combination with interferon-gamma J Leukoc Biol 58 585 594 1:CAS:528:DyaK2MXptleit70%3D 7595061
22. FM Krieg RY Andres KH Winterhalter 1995 Superparamagnetically labelled neutrophils as potential abscess-specific contrast agent for MRI Magn Reson Imaging 13 393 400 10.1016/0730-725X(94)00111-F 10.1016/0730-725X(94)00111-F 1:STN:280:DyaK2MzhtFKksg%3D%3D 7791549
23. S Metz G Bonaterra M Rudelius M Settles EJ Rummeny HE Daldrup-Link 2004 Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro Eur Radiol 14 1851 1858 10.1007/s00330-004-2405-2 10.1007/s00330-004-2405-2 15249981 (Pubitemid 39386634)
24. SM Moghimi AC Hunter JC Murray 2005 Nanomedicine: current status and future prospects FASEB J 19 311 330 10.1096/fj.04-2747rev 10.1096/fj.04-2747rev 1:CAS:528:DC%2BD2MXit1ygsLw%3D 15746175 (Pubitemid 40316520)
25. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 10.1016/0022-1759(83)90303-4 10.1016/0022-1759(83)90303-4 1:STN:280: DyaL2c%2FovFSmtw%3D%3D 6606682
26. K Muller JN Skepper M Posfai, et al. 2007 Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro Biomaterials 28 1629 1642 10.1016/j.biomaterials. 2006.12.003 10.1016/j.biomaterials.2006.12.003 17178155 (Pubitemid 46098969)
27. K Muller JN Skepper TY Tang, et al. 2008 Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging Biomaterials 29 2656 2662 10.1016/j.biomaterials.2008.03.006 10.1016/j.biomaterials.2008.03. 006 1:CAS:528:DC%2BD1cXksFKqsLg%3D 18377983
28. J Oca-Cossio H Mao N Khokhlova, et al. 2004 Magnetically labeled insulin-secreting cells Biochem Biophys Res Commun 319 569 575 10.1016/j.bbrc.2004.04.195 10.1016/j.bbrc.2004.04.195 1:CAS:528: DC%2BD2cXkslSjurs%3D 15178444 (Pubitemid 38725984)
29. Y Pan C Lloyd H Zhou, et al. 1997 Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation Nature 387 611 617 10.1038/42491 10.1038/42491 1:CAS:528:DyaK2sXktFCitLc%3D 9177350 1997Natur.387..611P (Pubitemid 27248766)
30. E Pawelczyk AS Arbab S Pandit E Hu JA Frank 2006 Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging NMR Biomed 19 581 592 10.1002/nbm.1038 10.1002/nbm.1038 1:CAS:528: DC%2BD28XpsFejur8%3D 16673357 (Pubitemid 44240784)
31. M Rausch P Hiestand D Baumann C Cannet M Rudin 2003 MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE Magn Reson Med 50 309 314 10.1002/mrm.10541 10.1002/mrm.10541 1:STN:280: DC%2BD3szksVaruw%3D%3D 12876707 (Pubitemid 36950850)
32. I Raynal P Prigent S Peyramaure A Najid C Rebuzzi C Corot 2004 Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10 Invest Radiol 39 56 63 10.1097/01.rli.0000101027.57021.28 10.1097/01.rli.0000101027.57021.28 1:CAS:528:DC%2BD2cXhtFSj 14701989 (Pubitemid 38030177)
33. P Reimer T Balzer 2003 Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications Eur Radiol 13 1266 1276 12764641
34. P Smirnov E Lavergne F Gazeau, et al. 2006 In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy Magn Reson Med 56 498 508 10.1002/mrm.20996 10.1002/mrm.20996 1:CAS:528:DC%2BD28XhtVeqt7vK 16897768 (Pubitemid 44338868)
35. Y Zhang SJ Dodd KS Hendrich M Williams C Ho 2000 Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration Kidney Int 58 1300 1310 10.1046/j.1523-1755.2000.00286.x 10.1046/j.1523-1755.2000.00286.x 1:STN:280:DC%2BD3cvotlyitQ%3D%3D 10972694 (Pubitemid 30678054)